Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khalid Al-Rasadi

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
European Heart Journal|May 2, 2023
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceMarina Cuchel, Frederick J Raal, Robert A Hegele, et al.
Frontiers in Endocrinology|June 2, 2023
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implementLaszlo Rosta, Adrienn Menyhart, Wael Al Mahmeed, et al.
Current Vascular Pharmacology|July 6, 2017
The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS FindingsAbdullah Shehab, Khalid Al-Rasadi, Mohamed Arafah, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 29, 2022
Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic healthElena Lo Presti, Domenico Nuzzo, Wael Al Mahmeed, et al.
Metabolites|January 21, 2023
Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical EvidenceGiuseppe Mainas, Luigi Nibali, Mark Ide, et al.
Vnitrni Lekarstvi|February 23, 2017
ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and DesignRichard Češka, György Paragh, Željko Reiner, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 24, 2023
Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert PanelDjordje S Popovic, Nikolaos Papanas, Theocharis Koufakis, et al.
Vnitrni Lekarstvi|February 23, 2017
ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic EpidemiologyRichard Češka, Tomáš Freiberger, Andrey V Susekov, et al.
Diabetology & Metabolic Syndrome|July 29, 2016
Impact of metabolic syndrome on lipid target achievements in the Arabian Gulf: findings from the CEPHEUS studyIbrahim Al-Zakwani, Wael Al Mahmeed, Abdullah Shehab, et al.
Oman Medical Journal|April 22, 2022
The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein CholesterolHilal Al-Sabti, Ali T Al-Hinai, Ibrahim Al-Zakwani, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
European Heart Journal|May 2, 2023
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidanceMarina Cuchel, Frederick J Raal, Robert A Hegele, et al.
Frontiers in Endocrinology|June 2, 2023
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implementLaszlo Rosta, Adrienn Menyhart, Wael Al Mahmeed, et al.
Current Vascular Pharmacology|July 6, 2017
The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS FindingsAbdullah Shehab, Khalid Al-Rasadi, Mohamed Arafah, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 29, 2022
Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic healthElena Lo Presti, Domenico Nuzzo, Wael Al Mahmeed, et al.
Metabolites|January 21, 2023
Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical EvidenceGiuseppe Mainas, Luigi Nibali, Mark Ide, et al.
Vnitrni Lekarstvi|February 23, 2017
ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Rationale and DesignRichard Češka, György Paragh, Željko Reiner, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 24, 2023
Glucometabolic Perturbations in Type 2 Diabetes Mellitus and Coronavirus Disease 2019: Causes, Consequences, and How to Counter Them Using Novel Antidiabetic Drugs - The CAPISCO International Expert PanelDjordje S Popovic, Nikolaos Papanas, Theocharis Koufakis, et al.
Vnitrni Lekarstvi|February 23, 2017
ScreenPro FH - Screening Project for Familial Hypercholesterolemia in Central, Southern and Eastern Europe: Basic EpidemiologyRichard Češka, Tomáš Freiberger, Andrey V Susekov, et al.
Diabetology & Metabolic Syndrome|July 29, 2016
Impact of metabolic syndrome on lipid target achievements in the Arabian Gulf: findings from the CEPHEUS studyIbrahim Al-Zakwani, Wael Al Mahmeed, Abdullah Shehab, et al.
Oman Medical Journal|April 22, 2022
The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein CholesterolHilal Al-Sabti, Ali T Al-Hinai, Ibrahim Al-Zakwani, et al.
Pageof 15